Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group.
about
Trial on refinement of early stage non-small cell lung cancer. Adjuvant chemotherapy with pemetrexed and cisplatin versus vinorelbine and cisplatin: the TREAT protocolPemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neckA Prospective Phase I/II Study: Combination Chemotherapy with Docetaxel and Pemetrexed as Second-Line Treatment in Patients with Stage IIIB/IV Non-Small Cell Lung CancerA phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignanciesEfficacies and adverse reactions of modified vitamin supplement programs before pemetrexed chemotherapy as a second-line treatment against epidermal growth factor receptor (EGFR) mutant wild-type lung adenocarcinoma.Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.Pemetrexed for the treatment of non-small-cell lung cancer.Emerging role of pemetrexed in ovarian cancer.Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed.Adaptation of a chemosensitivity assay to accurately assess pemetrexed in ex vivo cultures of lung cancerFront-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer.Pemetrexed for the treatment of non-small cell lung cancer.The current state of pemetrexed in ovarian cancer.Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions.Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis.Utilizing radiolabeled 3'-deoxy-3'-[18F]fluorothymidine with positron emission tomography to monitor the effect of dexamethasone on non-small cell lung cancer.Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review.Chronic p27 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor
P2860
Q28209997-8112B275-45EA-43AE-A308-3404BF39D4F0Q28347912-B86AE493-1162-45C1-8624-38FA63C95379Q30317149-BC2D0CE3-378D-4027-BB64-A10323CAE38EQ33391652-121BB58F-5A51-4FB1-B5CC-F5E8CAF4649CQ33427414-E99ED01F-6384-487F-9D2F-33725EF76D66Q34744444-6A0BBCEC-987A-4EC6-A333-FD50CF38B08BQ35003631-19BCE75D-426D-4720-9B33-6D5BD74F9788Q35015611-12D24329-387C-428B-8DEB-E299AFA593CAQ36429607-4C66538C-FFD3-449A-8ADE-9926CA1344E3Q36441443-1A8123E2-BC91-4163-ACC7-3CDC2680B172Q36591925-02C36CEB-3402-4F8E-A647-7F6D87952C3BQ36614907-4745AB5B-76E3-4D2D-93D4-128D5B112586Q37388593-BCBEC37D-DD2A-43A8-8360-A618EE260ECEQ38107552-E96F7B1C-82F8-405E-98FD-CBC900D7CDD6Q38125259-1B37E406-69B1-4F43-92D0-7A1D77CECDE5Q43707358-3FFE031F-484E-4D3A-BB64-CC6575D3D65BQ46170046-246302DA-C37C-4398-93D5-1FE6BA693D7EQ51757551-DB294ECB-2046-49EB-B3C0-8DA12474E1D7Q52718193-EEECDB75-B9BE-4C9F-8280-42E93646DDC6Q52828371-AE4125EE-48AF-444D-A9DE-08AEA9CEC49FQ55432585-7BB4EFB1-2FBB-49D4-AC60-913935BD8A43Q58098889-B4A4654D-9600-47BC-AC0B-7F9A151AC499
P2860
Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@ast
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@en
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@nl
type
label
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@ast
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@en
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@nl
prefLabel
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@ast
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@en
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@nl
P2093
P921
P1476
Multitargeted antifolate LY231 ...... Canada Clinical Trials Group.
@en
P2093
E Eisenhauer
J Iglesias
J J Rusthoven
P356
10.1200/JCO.1999.17.4.1194
P407
P577
1999-04-01T00:00:00Z